Real-World study tracks kidney cancer drug use outside the lab
NCT ID NCT04106349
First seen Sep 30, 2025 · Last updated May 14, 2026 · Updated 25 times
Summary
This study watches how patients with advanced kidney cancer are actually treated with the drug cabozantinib (Cabometyx), either alone or with nivolumab, in everyday medical practice. Researchers will track dosing changes, treatment delays, and quality of life in 150 adults in Belgium. The goal is to understand real-world use, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED OR METASTATIC RENAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AZ Delta
Roeselare, 8800, Belgium
-
AZ Glorieux
Ronse, 9600, Belgium
-
AZ Sint-Jan Brugge
Bruges, 8000, Belgium
-
AZ Sint-Lucas
Bruges, 8310, Belgium
-
AZ Turnhout
Turnhout, 2300, Belgium
-
CHC MontLegia
Liège, 4000, Belgium
-
CHR Citadelle Liège
Liège, 4000, Belgium
-
CHR Verviers
Verviers, 4800, Belgium
-
CHU Charleroi - site André Vésale
Montigny-le-Tilleul, 6110, Belgium
-
CHU Liège / Sart-Tilman
Liège, 4000, Belgium
-
CHWAPI
Tournai, 7500, Belgium
-
Clinique Saint-Luc Bouge
Bouge, 5004, Belgium
-
Clinique Saint-Pierre
Ottignies, 1340, Belgium
-
Hôpital Ambroise-Paré Mons
Mons, 7000, Belgium
-
Hôpital de Jolimont
La Louvière, 7100, Belgium
-
Imeldaziekenhuis
Bonheiden, 2820, Belgium
-
Onze-Lieve-vrouw Ziekenhuis Aalst
Aalst, 9300, Belgium
-
UZ Brussel
Brussels, 1090, Belgium
-
Universitair Ziekenhuis Gent
Ghent, 9000, Belgium
-
Ziekenhuis Oost-Limburg Genk
Genk, 3600, Belgium
Conditions
Explore the condition pages connected to this study.